Semaglutide

Service Description

Semaglutide is a medication used primarily for the treatment of type 2 diabetes and obesity. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which mimics the effects of the GLP-1 hormone to enhance glucose-dependent insulin secretion, slow gastric emptying, and reduce appetite, thus contributing to weight loss.